The aim of this study is to evaluate the use of RWD (claims data) as a tool for the differentiation between patients receiving empiric and targeted antibacterial therapy.

Download

Estimating the Global Epidemiology of Amyloid Light-chain Amyloidosis With an Incidence-to-prevalence Model

View Now